Literature DB >> 9792408

A frequent TG deletion near the polyadenylation signal of the human HEXB gene: occurrence of an irregular DNA structure and conserved nucleotide sequence motif in the 3' untranslated region.

F E Kleiman1, A O Ramírez, R Dodelson de Kremer, R A Gravel, C E Argaraña.   

Abstract

While screening for new mutations in the HEXB gene, which encodes the beta-subunit of beta-hexosaminidase, a TG deletion (deltaTG) was found in the 3' untranslated region (3'UTR) of the gene, 7 bp upstream from the polyadenylation signal. Examination of DNA samples of 145 unrelated Argentinean individuals from different racial backgrounds showed that the deltaTG allele was present with a frequency of approximately 0.1, compared with the wild-type (WT) allele. The deletion was not associated with infantile or variant forms of Sandhoff disease when present in combination with a deleterious allele. Total Hex and Hex B enzymatic activities measured in individuals heterozygous for deltaTG and a null allele, IVS-2 + 1G-->A (G-->A), were approximately 30% lower than the activities of G-->A/WT individuals. Analysis of the HEXB mRNA from leukocytes of deltaTG/WT individuals by RT-PCR of the 3'UTR showed that the deltaTG allele is present at lower level than the WT allele. By polyacrylamide gel electrophoresis, it was determined that a PCR fragment containing the +TG version of the 3'UTR of the HEXB gene had an irregular structure. On inspection of genes containing a TG dinucleotide upstream from the polyadenylation signal we found that this dinucleotide was part of a conserved sequence (TGTTTT) immersed in a A/T-rich region. This sequence arrangement was present in more than 40% analyzed eukaryotic mRNAs, including in the human, mouse and cat HEXB genes. The significance of the TG deletion in reference to Sandhoff disease as well as the possible functional role of the consensus sequence and the DNA structure of the 3'UTR are considered.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792408     DOI: 10.1002/(SICI)1098-1004(1998)12:5<320::AID-HUMU5>3.0.CO;2-H

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  6 in total

Review 1.  A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants.

Authors:  Jian-Min Chen; Claude Férec; David N Cooper
Journal:  Hum Genet       Date:  2006-06-29       Impact factor: 4.132

2.  Molecular and functional analysis of the HEXB gene in Italian patients affected with Sandhoff disease: identification of six novel alleles.

Authors:  Stefania Zampieri; Mirella Filocamo; Emanuele Buratti; Marina Stroppiano; Kristian Vlahovicek; Natalia Rosso; Eleonora Bignulin; Stefano Regis; Franco Carnevale; Bruno Bembi; Andrea Dardis
Journal:  Neurogenetics       Date:  2008-08-29       Impact factor: 2.660

3.  Novel Mutations in Sandhoff Disease: A Molecular Analysis among Iranian Cohort of Infantile Patients.

Authors:  H Aryan; O Aryani; K Banihashemi; T Zaman; M Houshmand
Journal:  Iran J Public Health       Date:  2012-03-31       Impact factor: 1.429

4.  Is the Expression of Androgen Receptor Protein Associated With the Length of AC Repeats in the Type III 5-α Reductase Gene in Prostate Cancer Patients?

Authors:  Jong Mok Park; Ki Hak Song; Jae Sung Lim; Jin Woo Kim; Chong Koo Sul
Journal:  Korean J Urol       Date:  2013-06-12

5.  The 3' processing factor CstF functions in the DNA repair response.

Authors:  Nurit Mirkin; Danae Fonseca; Samia Mohammed; Murat A Cevher; James L Manley; Frida E Kleiman
Journal:  Nucleic Acids Res       Date:  2008-02-05       Impact factor: 16.971

6.  Intronic cleavage and polyadenylation regulates gene expression during DNA damage response through U1 snRNA.

Authors:  Emral Devany; Ji Yeon Park; Michael R Murphy; George Zakusilo; Jorge Baquero; Xiaokan Zhang; Mainul Hoque; Bin Tian; Frida E Kleiman
Journal:  Cell Discov       Date:  2016-06-14       Impact factor: 10.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.